Quipt Home Medical Corp. QIPT
We take great care to ensure that the data presented and summarized in this overview for Quipt Home Medical Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding QIPT
View all-
Claret Asset Management Corp4.47MShares$9.61 Million2.15% of portfolio
-
Forager Capital Management, LLC Birmingham, AL4.2MShares$9.03 Million5.36% of portfolio
-
Kanen Wealth Management LLC Coral Springs, FL2.97MShares$6.38 Million2.79% of portfolio
-
Black Rock Inc. New York, NY2MShares$4.31 Million0.0% of portfolio
-
Royce & Associates LP1.98MShares$4.26 Million0.06% of portfolio
-
First Manhattan CO New York, NY1.65MShares$3.55 Million0.02% of portfolio
-
Russell Investments Group, Ltd.911KShares$1.96 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA732KShares$1.57 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA713KShares$1.53 Million0.0% of portfolio
-
State Street Corp Boston, MA651KShares$1.4 Million0.0% of portfolio
Latest Institutional Activity in QIPT
Top Purchases
Top Sells
About QIPT
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Insider Transactions at QIPT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Mar 22
2025
|
Hardik Mehta Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
343,347
+48.37%
|
-
|
|
Mar 22
2025
|
Mark Alan Miles Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+50.0%
|
-
|
|
Mar 22
2025
|
Thomas Roehrig Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+38.87%
|
-
|
|
Mar 22
2025
|
Brian Joseph Wessel Director |
BUY
Grant, award, or other acquisition
|
Direct |
183,135
+48.14%
|
-
|
|
Mar 22
2025
|
David Bachelder Exec. VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+47.44%
|
-
|
|
Mar 22
2025
|
Kevin A. Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
174,767
+38.61%
|
-
|
|
Mar 22
2025
|
Gregory John Crawford President/CEO |
BUY
Grant, award, or other acquisition
|
Direct |
936,000
+25.26%
|
-
|
|
Mar 22
2025
|
Patrick Dennis Gamble Exec. VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+24.98%
|
-
|
|
Mar 22
2025
|
Mark Alan Greenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
211,504
+28.59%
|
-
|
|
Mar 14
2025
|
Gregory John Crawford President/CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
118,750
+6.08%
|
-
|
|
Mar 14
2025
|
Mark Alan Greenberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
115,625
+26.74%
|
-
|
|
Mar 14
2025
|
Brian Joseph Wessel Director |
SELL
Bona fide gift
|
Direct |
98,875
-87.5%
|
-
|
|
Mar 14
2025
|
Brian Joseph Wessel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
70,625
+38.46%
|
-
|
|
Mar 14
2025
|
Hardik Mehta Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
92,500
-80.0%
|
-
|
|
Mar 14
2025
|
Hardik Mehta Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
115,624
+50.0%
|
-
|
|
Mar 14
2025
|
Thomas Roehrig Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+38.46%
|
-
|
|
Mar 14
2025
|
Kevin A. Carter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
53,124
+34.0%
|
-
|
|
Dec 26
2024
|
Patrick Dennis Gamble Exec. VP Operations |
BUY
Open market or private purchase
|
Direct |
17,000
+19.43%
|
$34,000
$2.45 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.11M shares |
|---|---|
| Open market or private purchase | 17K shares |
| Exercise of conversion of derivative security | 513K shares |
| Bona fide gift | 191K shares |
|---|